WebDysosmobacter Welbionis. Researchers leveraging Akkermansia know-how to accelerate probiotic candidate development. 18-May-2024 By Stephen Daniells Knowledge gleaned from the commercialization of Akkermansia muciniphila should lead to an accelerated … WebJun 24, 2024 · A strictly anaerobic, Gram-stain-negative, non-spore-forming, non-motile, non-pigmented bacterium, strain J115T, was isolated from human faeces. Cells of strain J115T were straight rods, generally 1.8–3.0 µm, but could be up to 18 µm long. Growth occurred below 2 % (w/v) NaCl and 2 % (v/v) bile. Strain J115T produced acid from myo …
Dysosmobacter welbionis gen. nov., sp. nov., isolated from …
WebJun 9, 2024 · An analysis of 12,000 fecal samples from around the world found that Dysosmobacter welbionis is present in 70% of the population, "which is huge," but that it was less present in people with type II diabetes. When testing the action of the bacterium in mice, the scientists found that it increased the number of mitochondria (a type of power ... WebJun 9, 2024 · The UCLouvain team including Emilie Moens de Hase (doctoral student) and Tiphaine Le Roy (post-doctoral fellow) then tested the action of Dysosmobacter welbionis in mice. The bacteria increased the number of mitochondria, thereby lowering sugar levels and weight, in addition to exerting strong anti-inflammatory effects. chimeric plasmid
科学网—科微学术 宏基因组及培养组学技术在粪菌移植中的应用
WebJun 16, 2024 · 我们最近分离并描述了反刍球菌科的一个新种:韦氏非渗透杆菌(Dysosmobacter Welbionis)。 这种细菌与一种尚未培养的物种密切相关,这种物种一直被认为与瘦身有关:吉勒蒙迪振荡螺菌(Oscillospira Guillermondii)。 WebJun 3, 2024 · cultures of Dysosmobacter welbionis J115T by oral gavage at the dose 1.0 109 cfu /0.2 ml of cultivable, live bacteria per day and per mice (HFD J115 fresh) and control groups were treated with an oral gavage of an equivalent volume of PBS-carbonate buffer. Treatment continued for 6 weeks. Mice were euthanized after a 6-hour fasting period. chimeric polynucleotide